Cns Pharmaceuticals, Inc. (CNSP) — DEF 14A Filings
All DEF 14A filings from Cns Pharmaceuticals, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
CNS Pharma Seeks Massive Share Increase, Signaling Potential Dilution
— Oct 24, 2025 Risk: high
CNS Pharmaceuticals, Inc. (CNSP) is holding its Annual Meeting of Stockholders on November 17, 2025, virtually, to address several critical proposals. The compa -
CNS Pharmaceuticals Files Definitive Proxy Statement
— Oct 28, 2024 Risk: low
CNS Pharmaceuticals, Inc. filed its definitive proxy statement on October 28, 2024, for its annual meeting of stockholders. The filing outlines the proposals to -
CNS Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders on April 30
— Apr 10, 2024 Risk: low
CNS Pharmaceuticals, Inc. (CNSP) filed a Proxy Statement (DEF 14A) with the SEC on April 10, 2024. The 2024 Annual Meeting of Stockholders for CNS Pharmaceutica
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX